Current
TRIMTECH Therapeutics
Life Sciences
•
Republic of Ireland
•
Early Stage
•
2026
TRIMTECH is developing novel small molecule therapies that target and degrade protein aggregates associated with neurodegenerative disorders, opening up much needed treatment approaches for conditions such as Alzheimer’s disease.
Looking for funding?
We’ve already helped hundreds of ambitious businesses in the UK and Ireland to accelerate their growth. If you’re looking for a minority investment partner that can provide long-term, flexible funding and support, please get in touch with our team today.
